Frontiers in Pharmacology,
Journal Year:
2022,
Volume and Issue:
13
Published: March 11, 2022
The
initial
responses
to
standard
chemotherapies
among
prostate
cancer
(PCa)
patients
are
usually
significant,
while
most
of
them
will
finally
develop
drug
resistance,
rendering
with
limited
therapies.
To
discover
new
regimens
for
the
treatment
PCa
including
resistant
PCa,
natural
products,
richest
source
bioactive
compounds,
can
serve
as
a
library
screening
and
identifying
promising
candidates,
flavones
such
apigenin
genistein
have
been
used
in
lab
clinical
trials
treating
over
decades.
In
this
mini-review,
we
take
look
into
progress
genistein,
which
isomers,
past
decade.
While
possessing
very
similar
structure,
these
two
isomers
both
target
same
signaling
pathways;
they
also
found
work
differently
cells.
Given
that
more
combinations
being
developed
tested,
appears
be
option
approved.
anticancer
efficacies
confirmed
by
in-vitro
in-vivo
studies,
their
applications
remain
validated
trials.
Information
gained
may
provide
important
information
development
potential
application
PCa.
ACS Omega,
Journal Year:
2024,
Volume and Issue:
9(9), P. 10030 - 10048
Published: Feb. 22, 2024
Skin
cancer
(SC)
poses
a
global
threat
to
the
healthcare
system
and
is
expected
increase
significantly
over
next
two
decades
if
not
diagnosed
at
an
early
stage.
Early
diagnosis
crucial
for
successful
treatment,
as
disease
becomes
more
challenging
cure
it
progresses.
However,
identifying
new
drugs,
achieving
clinical
success,
overcoming
drug
resistance
remain
significant
challenges.
To
overcome
these
obstacles
provide
effective
understand
causes
of
skin
cancer,
how
cells
grow
divide,
factors
that
affect
cell
growth,
occurs.
In
this
review,
we
have
explained
various
therapeutic
approaches
SC
treatment
via
ligands,
targeted
photosensitizers,
natural
synthetic
drugs
SC,
epigenetic
approach
management
melanoma,
photodynamic
therapy,
therapy
BRAF-mutated
melanoma.
This
article
also
provides
detailed
summary
are
in
managing
melanoma
reducing
occurrence
stages
focuses
on
current
status
future
prospects
therapies
available
cancer.
Foods,
Journal Year:
2025,
Volume and Issue:
14(3), P. 347 - 347
Published: Jan. 21, 2025
Bee
pollen
is
characterized
by
an
exceptional
diversity
and
abundance
of
micronutrients
bioactive
phytochemicals.
This
richness
remains
very
sparsely
investigated,
but
accumulating
evidence
strongly
supports
a
promising
future
for
bee
in
human
nutrition
medicine.
Epigenetic
regulation
among
the
most
compelling
biomedical
topics
that
remain
completely
untapped
derivative
research.
In
our
current
research,
we
identified
numerous
ubiquitous
compounds
are
consistently
present
this
matrix,
regardless
its
botanical
geographical
origins,
have
been
well
studied
documented
as
epigenetic
regulators
recent
years.
Given
relative
newness
both
research
studies
within
nutritional,
pharmaceutical,
medical
sciences,
review
aims
to
bridge
these
valuable
fields
advance
related
experimental
investigations.
To
best
knowledge,
first
work
has
aimed
comprehensively
investigate
modulatory
potential
compounds.
Our
findings
also
unveiled
several
intriguing
phenomena,
such
dual
effect
same
compound
depending
on
cellular
context
or
some
cross-generational
heritability
traits.
Although
whole
extract
still
lacking,
study
clearly
indicates
avenue
worth
further
We
hope
constitutes
foundational
cornerstone
investigations
Cell Biochemistry and Biophysics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 19, 2025
Abstract
Idiopathic
Pulmonary
Fibrosis
(IPF)
is
a
severe,
rapidly
advancing
disease
that
drastically
diminishes
life
expectancy.
Without
treatment,
it
can
progress
to
lung
cancer.
The
precise
etiology
of
IPF
remains
unknown,
but
inflammation
and
damage
the
alveolar
epithelium
are
widely
thought
be
pivotal
in
its
development.
Research
has
indicated
activating
NLRP3
inflammasome
crucial
mechanism
pathogenesis,
as
triggers
release
pro-inflammatory
cytokines
such
IL-1β,
IL-18,
TGF-β.
These
contribute
myofibroblast
differentiation
extracellular
matrix
(ECM)
accumulation.
Currently,
treatment
options
for
limited.
Only
two
FDA-approved
medications,
pirfenidone
nintedanib,
available.
While
these
drugs
decelerate
progression,
they
come
with
range
side
effects
do
not
cure
disease.
Additional
strategies
primarily
involve
supportive
care
therapy.
Emerging
research
highlighted
numerous
flavonoids
derived
from
traditional
medicines
inhibit
critical
regulators
responsible
inflammasome.
show
promise
potential
therapeutic
agents
managing
IPF,
offering
new
avenue
targets
core
inflammatory
processes
this
debilitating
condition.
Graphical
Basic & Clinical Pharmacology & Toxicology,
Journal Year:
2021,
Volume and Issue:
129(6), P. 397 - 415
Published: Sept. 2, 2021
Cancer
is
known
as
a
second
major
cause
of
death
globally.
Nowadays,
several
modalities
have
been
developed
for
the
treatment
cancer.
Radiotherapy
and
chemotherapy
are
most
common
in
countries.
However,
newer
such
immunotherapy
targeted
therapy
drugs
can
kill
cancer
cells
with
minimal
side
effects.
All
anticancer
agents
work
based
on
killing
cells.
Numerous
studies
ongoing
to
more
effectively
without
increasing
effects
normal
tissues.
The
combination
low
toxic
interesting
this
aim.
Curcumin
one
herbal
that
has
shown
properties.
It
regulate
immune
system
responses
against
Furthermore,
curcumin
potentiate
cell
signalling
pathways
attenuate
survival
knowledge
how
induces
cancers
improve
therapeutic
efficiency.
In
review,
regulatory
different
mechanisms
their
will
be
discussed.
we
explain
may
other
or
radiotherapy
through
modulation
apoptosis,
mitotic
catastrophe,
senescence,
autophagy
ferroptosis.
Molecules,
Journal Year:
2022,
Volume and Issue:
27(13), P. 4304 - 4304
Published: July 4, 2022
Plant
bioactive
compounds,
particularly
apigenin,
have
therapeutic
potential
and
functional
activities
that
aid
in
the
prevention
of
infectious
diseases
many
mammalian
bodies
promote
tumor
growth
inhibition.
Apigenin
is
a
flavonoid
with
low
toxicities
numerous
properties
due
to
which
it
has
been
considered
as
traditional
medicine
for
decades.
shows
synergistic
effects
combined
treatment
sorafenib
HepG2
human
cell
line
(HCC)
less
time
statistically
reduces
viability
cells,
migration,
gene
expression
apoptosis.
The
combination
anti-cancerous
drugs
apigenin
shown
health
promoting
against
various
cancers.
It
can
prevent
mobility,
maintain
cycle
stimulate
immune
system.
also
suppresses
mTOR
activity
raises
UVB-induced
phagocytosis
cancerous
proliferation
growth.
high
safety
threshold,
active
(anti-cancer)
doses
be
gained
by
consuming
vegetable
rich
diet.
boosted
autophagosome
formation,
decreased
activated
autophagy
preventing
PI3K
pathway,
specifically
cells.
This
paper
provides
an
updated
overview
apigenin's
beneficial
anti-inflammatory,
antibacterial,
antiviral,
anticancer
effects,
making
step
right
direction
therapeutics.
study
critically
analyzed
effect
on
cancer
signaling
pathways
including
PI3K/AKT/MTOR,
JAK/STAT,
NF-κB
ERK/MAPK
pathways.
International Journal of Biological Sciences,
Journal Year:
2023,
Volume and Issue:
19(10), P. 3029 - 3041
Published: Jan. 1, 2023
Nuclear
factor
erythroid
2-related
2
(Nrf2),
a
transcription
that
regulates
redox
homeostasis,
plays
pivotal
role
in
several
cellular
processes
such
as
cell
proliferation
and
survival,
has
been
found
to
be
aberrantly
activated
many
cancers.As
one
of
the
key
oncogenes,
Nrf2
represents
an
important
therapeutic
target
for
cancer
treatment.Research
unraveled
main
mechanisms
underlying
pathway
regulation
promoting
tumorigenesis.Many
efforts
have
made
develop
potent
inhibitors,
clinical
trials
are
being
conducted
on
some
these
inhibitors.Natural
products
well-recognized
valuable
source
development
novel
therapeutics
cancer.So
far,
number
natural
compounds
identified
apigenin,
luteolin,
quassinoids
including
brusatol
brucein
D.
These
inhibitors
mediate
oxidant
response
display
effects
different
types
human
cancers.In
this
article,
we
reviewed
structure
function
Nrf2/Keap1
system
with
emphasis
their
biological
cancer.The
current
status
regarding
potential
treatment
was
also
summarized.It
is
hoped
review
will
stimulate
research
naturally
occurring
candidates
treatment.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
165, P. 114706 - 114706
Published: July 1, 2023
Acute
myocardial
infarction
remains
the
leading
cause
of
death
in
humans.
Timely
restoration
blood
perfusion
to
ischemic
myocardium
most
effective
strategy
treatment
acute
infarction,
which
can
significantly
reduce
morbidity
and
mortality.
However,
after
flow
reperfusion,
injury
will
aggravate
induce
apoptosis
cardiomyocytes,
a
process
called
ischemia-reperfusion
injury.
Studies
have
shown
that
loss
cardiomyocytes
caused
by
oxidative
stress,
iron
load,
increased
lipid
peroxidation,
inflammation
mitochondrial
dysfunction,
etc.,
are
involved
In
recent
years,
with
in-depth
research
on
pathology
injury,
people
gradually
realized
there
is
new
form
cell
pathological
namely
ferroptosis.
A
number
studies
found
tissue
patients
changes
closely
related
ferroptosis,
such
as
metabolism
disorder,
reactive
oxygen
species
free
radicals.
Natural
plant
products
resveratrol,
baicalin,
cyanidin-3-O-glucoside,
naringenin,
astragaloside
IV
also
exert
therapeutic
effects
correcting
imbalance
these
ferroptosis-related
factors
expression
levels.
Combining
our
previous
studies,
this
review
summarizes
regulatory
mechanism
natural
intervening
ferroptosis
order
provide
reference
information
for
development
targeted
inhibitor
drugs
cardiovascular
diseases.
Metabolites,
Journal Year:
2023,
Volume and Issue:
13(3), P. 404 - 404
Published: March 9, 2023
It
has
been
demonstrated
that
cancer
stem
cells
(CSCs)
go
through
metabolic
changes
differentiate
them
from
non-CSCs.
The
altered
metabolism
of
CSCs
plays
a
vital
role
in
tumor
initiation,
progression,
immunosuppression,
and
resistance
to
conventional
therapy.
Therefore,
defining
the
CSC
carcinogenesis
emerged
as
main
focus
research.
Two
natural
flavonoids,
apigenin
isovitexin,
have
shown
act
synergistically
with
chemotherapeutic
drugs
by
sensitizing
CSCs,
ultimately
leading
improved
therapeutic
efficacy.
aim
this
study
is
present
critical
broad
evaluation
anti-CSC
capability
isovitexin
different
cancers
novel
untapped
compounds
for
developing
drugs.
A
thorough
review
included
literature
supports
strong
association
between
activity
treatment
or
isovitexin.
Additionally,
it
affected
reduced
various
mechanisms,
including
suppression
Wnt/β-catenin
signaling
pathway,
inhibition
nuclear
factor-κB
protein
expression,
downregulation
cell
cycle
via
upregulation
p21
cyclin-dependent
kinases.
findings
demonstrate
are
potent
candidates
treating
due
their
antagonistic
effects
on
metabolism.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(10), P. 5569 - 5569
Published: May 20, 2024
Due
to
its
propensity
metastasize,
cancer
remains
one
of
the
leading
causes
death
worldwide.
Thanks
in
part
their
intrinsic
low
cytotoxicity,
effects
flavonoid
family
prevention
and
treatment
various
human
cancers,
both
vitro
vivo,
have
received
increasing
attention
recent
years.
It
is
well
documented
that
Apigenin
(4′,5,7-trihydroxyflavone),
among
other
flavonoids,
able
modulate
key
signaling
molecules
involved
initiation
cell
proliferation,
invasion,
metastasis,
including
JAK/STAT,
PI3K/Akt/mTOR,
MAPK/ERK,
NF-κB,
Wnt/β-catenin
pathways,
as
oncogenic
non-coding
RNA
network.
Based
on
these
premises,
aim
this
review
emphasize
some
events
through
which
suppresses
focusing
specifically
ability
target
molecular
pathways
angiogenesis,
epithelial-to-mesenchymal
transition
(EMT),
maintenance
stem
cells
(CSCs),
cycle
arrest,
death.